LighterFor GPs, hepatologists and dietitians
A patient who arrives knowing their numbers.
A tracking and education app for steatotic liver disease. Patients use it. You recommend it.
What the patient gets
A record they keep themselves, in plain language, that points back to you.
Their results as a trend
ALT, AST, GGT, platelets, FIB-4 with the published cut-offs, 1.3 (2.0 over 65) and 2.67, FibroScan stiffness and CAP, weight, waist and blood pressure. Typed in, or read from a photographed report. The ALT, weight and stiffness charts are free, and so is reading the first blood and scan report. Several measures on one chart is part of Plus.
Reminders timed to you
Bloods one to two weeks before a review, scans at the interval you set, surveillance reminders the patient switches on.
Education matched to diagnosis
Short lessons for MASLD, MetALD and ALD, four more for cirrhosis. No weight-loss push with cirrhosis; abstinence as ordinary care in ALD.
The four pillars, without the lecture
Eating, movement, alcohol and weight. One small step each, and a fortnightly food check-in. No meal logging.
What you get
A better consultation
- A summary the patient brings: results with dates, FIB-4, and what they changed and when.
- Fewer "what was my ALT" conversations, more time on what to do next.
- Consistent messages. The advice follows the 2024 EASL–EASD–EASO guideline and GESA guidance, cites its sources, and says on screen that your plan comes first.
What it is not
The boundaries matter as much as the features.
What it leaves to you
It never infers cirrhosis, stages disease, or tells a patient they are safe. Cirrhosis is a patient-entered flag on your advice, and it changes the guidance rather than the numbers.
Not a data pipeline
The record stays on the phone. No account, and nothing in it is sent unless the patient shares or exports it.
Your plan comes first
Every screen that carries general guidance says so. The app's job is to make the patient's next visit with you more useful.
Recommending it
Tell the patient the name.
LighterLiver is in testing on iPhone only. App Store release to follow.
Clinics can ask for access codes that cover Plus for their patients. Write to support@lighterliver.com.
Clinic links, so you can see uptake among your own patients, are being planned and are not built yet. Made in Melbourne by a hepatologist; the clinical content is reviewed and dated.
LighterLiver is for adults who have been told by a doctor that they have, or may have, fatty liver disease. It is for use alongside their usual medical care. It is not for patients who have had ascites, hepatic encephalopathy, variceal bleeding or jaundice from their liver; it asks at setup and stops tracking. It is a tracking and education tool. It does not diagnose.